Ra­di­oli­gands are go­ing on air: Ak­tis gains third Big Phar­ma backer

3 years ago
Financing
Startups

Search­ing for new TCR tar­gets, im­munother­a­py start­up emerges with Stan­ford tech, $40M round

3 years ago
Financing
Startups

Af­ter wrestling with the San­doz prob­lem for sev­er­al years, Vas Narasimhan set­tles on a spin­out

3 years ago
Deals

Pfiz­er's Paxlovid on­ly helped se­niors avoid hos­pi­tal­iza­tion and death, new NE­JM study finds

3 years ago
Coronavirus

In­ovio agrees to shell out $44M to set­tle Covid-19 vac­cine law­suit

3 years ago
Pharma
Coronavirus

House in­ves­ti­gates Trump’s ‘in­ap­pro­pri­ate’ pres­sure on FDA dur­ing the pan­dem­ic

3 years ago
FDA+
Coronavirus

US con­sid­ers use of ex­pired mon­key­pox vac­cines amid ris­ing de­mand for dos­es

3 years ago
Pharma

Ther­mo Fish­er opens its sec­ond site in a week, this time clos­er to its Mass­a­chu­setts head­quar­ters

3 years ago
Manufacturing

Ab­b­Vie re-ups so­cial and dig­i­tal cor­po­rate cam­paign star­ring re­al pa­tients and em­ploy­ees

3 years ago
Pharma
Marketing

Klick Health opens in-house pro­duc­tion stu­dio, along with new brand­ing and in­flu­encer busi­ness­es

3 years ago
Pharma
Marketing

PACT Phar­ma sus­pends sole clin­i­cal tri­al

3 years ago
People
Pharma

In­ter­change­abil­i­ty with­out switch­ing stud­ies: FDA ex­plains why a new Lu­cen­tis biosim­i­lar may be a game-chang­er

3 years ago
Pharma
FDA+

Ex-Kad­mon con­sul­tant faces up to 20 years in prison fol­low­ing guilty plea over in­sid­er trad­ing

3 years ago
Pharma
Law

Re­silience part­ners with the Cal­i­for­nia In­sti­tute for Re­gen­er­a­tive Med­i­cine to help cell ther­a­py star­tups

3 years ago
Cell/Gene Tx
Manufacturing

Wom­en's health biotech nabs new an­timi­cro­bial treat­ment; Ovid finds part­ner for neu­ro­science col­lab­o­ra­tion

3 years ago
News Briefing

Fo­cus­ing on cut­ting down sup­ply is­sues, ra­di­oli­gand biotech Ad­van­Cell rais­es $12M

3 years ago
R&D

Two de­cen­tral­ized tri­als star­tups prove they're not im­mune to broad­er wave of biotech lay­offs

3 years ago
People

Covid-19 roundup: Bi­va­lent vac­cines to be au­tho­rized by La­bor Day — re­port; Mod­er­na knocks on FDA's door for ...

3 years ago
Coronavirus

'Noth­ing es­capes our sci­en­tist­s': A hand­ful of biotechs gear up work on mon­key­pox

3 years ago
R&D

Sono­ma Bio to ce­ment its roots in Seat­tle with a new wa­ter­front man­u­fac­tur­ing and R&D site

3 years ago
R&D
Cell/Gene Tx

Blue­bird’s reg­u­la­to­ry chief de­parts two days af­ter his­toric gene ther­a­py nod to join Flag­ship’s Tessera

3 years ago
People

Na­tal­ie Holles tests the Nas­daq wa­ters with Third Har­mon­ic IPO

3 years ago
Financing

Why does the FDA se­lect cer­tain drugs for ad­comm meet­ings? Re­searchers want to know

3 years ago
Pharma
FDA+

In­di­v­ior fails to es­cape class ac­tion law­suit in Sub­ox­one case

3 years ago
Pharma
Law
First page Previous page 473474475476477478479 Next page Last page
A service from the Financial Times